Pyridoxal-5′-phosphate (PLP) is in most patients the effective treatment for pyridox(am)ine-5′-phosphate oxidase (PNPO) deficiency, a rare autosomal recessive cause of neonatal-onset developmental and epileptic encephalopathy. The gene discussed is PNPO; the disease is developmental and epileptic encephalopathy.